Search by Drug Name or NDC
NDC 00113-0401-62 Zephrex D 30 mg/1 Details
Zephrex D 30 mg/1
Zephrex D is a ORAL CAPSULE, GELATIN COATED in the HUMAN OTC DRUG category. It is labeled and distributed by L. Perrigo Company. The primary component is PSEUDOEPHEDRINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Pseudoephedrine is used to relieve nasal congestion caused by colds, allergies, and hay fever. It is also used to temporarily relieve sinus congestion and pressure. Pseudoephedrine will relieve symptoms but will not treat the cause of the symptoms or speed recovery. Pseudoephedrine is in a class of medications called nasal decongestants. It works by causing narrowing of the blood vessels in the nasal passages.
Related Packages: 00113-0401-62Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Pseudoephedrine
Product Information
| NDC | 00113-0401 |
|---|---|
| Product ID | 0113-0401_ad24e53e-53b1-46e5-a135-1d35d6601ef0 |
| Associated GPIs | 4210102010A120 |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Zephrex D |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | pseudoephedrine hydrochloride |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | CAPSULE, GELATIN COATED |
| Route | ORAL |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/1 |
| Substance Name | PSEUDOEPHEDRINE HYDROCHLORIDE |
| Labeler Name | L. Perrigo Company |
| Pharmaceutical Class | Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
Package Images
NDC 00113-0401-62 (00113040162)
| NDC Package Code | 0113-0401-62 |
|---|---|
| Billing NDC | 00113040162 |
| Package | 24 BLISTER PACK in 1 CARTON (0113-0401-62) / 1 CAPSULE, GELATIN COATED in 1 BLISTER PACK |
| Marketing Start Date | 2017-04-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 5468a7e2-361b-494f-9ca3-1b62f3819f65 Details
Uses
Do not use
if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have
Stop use and ask a doctor if
Keep out of reach of children.
Directions
|
adults and children 12 years and over |
|
|
children ages 6 to under 12 years |
|
|
children under 6 years |
do not use this product in children under 6 years of age |
Inactive ingredients
Package/Label Principal Display Panel
NEW DOSAGE FORM
MAXIMUM STRENGTH
ZEPHREX-D ®
CONGESTION
Pseudoephedrine HCl 30 mg
Nasal Decongestant
METH BLOCKING TAREX® TECHNOLOGY ™
Non-Drowsy
Relieves
Nasal & Sinus Congestion
Sinus Pressure
Easy-to-take softgels.
Individually sealed.
Actual Size
Fast-acting nasal decongestant goes to work in as little as 30 minutes. With advanced meth-blocking technology for safer communities.
24 softgels
INGREDIENTS AND APPEARANCE
| ZEPHREX D
pseudoephedrine hydrochloride capsule, gelatin coated |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Labeler - L. Perrigo Company (006013346) |